| 3616 |
1392: Increase, Oxidative Stress |
495: Repressed expression of steroidogenic enzymes |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3617 |
26: Antagonism, Androgen receptor |
2080: Impaired, blood testis barrier |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3618 |
2080: Impaired, blood testis barrier |
520: Decreased sperm quantity or quality in the adult, Decreased fertility |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3619 |
520: Decreased sperm quantity or quality in the adult, Decreased fertility |
1863: Decrease, Reproduction |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3620 |
1690: Decrease, circulating testosterone levels |
1758: Impaired, Spermatogenesis |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3621 |
1758: Impaired, Spermatogenesis |
520: Decreased sperm quantity or quality in the adult, Decreased fertility |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3622 |
1758: Impaired, Spermatogenesis |
1863: Decrease, Reproduction |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3623 |
495: Repressed expression of steroidogenic enzymes |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Sep 3, 2025 |
Sep 3, 2025 |
None
|
| 3624 |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
1696: Decrease of egg production and cummulative fecundity |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3625 |
1696: Decrease of egg production and cummulative fecundity |
1863: Decrease, Reproduction |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3626 |
1066: Promotion, SIX1 positive progenitor cells in endometrium |
1068: Endometrial squamous metaplasia, Increase |
Sep 3, 2025 |
Sep 18, 2025 |
1 AOP
|
| 3627 |
1066: Promotion, SIX1 positive progenitor cells in endometrium |
772: Increase, Hyperplasia (glandular epithelial cells of endometrium) |
Sep 3, 2025 |
Sep 18, 2025 |
1 AOP
|
| 3628 |
2274: Androgen receptor activation, increased |
2365: AGD, increased |
Sep 5, 2025 |
Sep 5, 2025 |
1 AOP
|
| 3629 |
2362: Redox cycling |
2363: Mito ROS dysfunction |
Sep 7, 2025 |
Oct 3, 2025 |
1 AOP
|
| 3632 |
1392: Increase, Oxidative Stress |
1767: Increase, Protein oxidation |
Sep 8, 2025 |
Sep 8, 2025 |
7 AOPs
|
| 3633 |
1767: Increase, Protein oxidation |
1446: Decrease, Coupling of OXPHOS |
Sep 8, 2025 |
Sep 8, 2025 |
3 AOPs
|
| 3634 |
1767: Increase, Protein oxidation |
179: Decrease, Fatty acid β-oxidation |
Sep 8, 2025 |
Sep 8, 2025 |
3 AOPs
|
| 3635 |
179: Decrease, Fatty acid β-oxidation |
1771: Decrease, ATP pool |
Sep 8, 2025 |
Sep 8, 2025 |
3 AOPs
|
| 3636 |
1767: Increase, Protein oxidation |
1505: Cell cycle disruption |
Sep 8, 2025 |
Sep 8, 2025 |
1 AOP
|
| 3637 |
1542: Inhibition, Mitochondrial complex III |
177: Increase, Mitochondrial dysfunction |
Sep 24, 2025 |
Oct 2, 2025 |
1 AOP
|
| 3638 |
2258: Inhibition, monocarboxylate transporter 8 (MCT8) |
280: T4 in neuronal tissue, Decreased |
Sep 29, 2025 |
Sep 29, 2025 |
None
|
| 3639 |
1267: Decrease, Ecdysis motor program activity |
993: Decrease, Abdominal muscle contraction |
Sep 29, 2025 |
Sep 29, 2025 |
3 AOPs
|
| 3640 |
103: Increase, EcR hyperactivation |
2373: Increase, Mis-timed EcR-responsive NR cascade |
Sep 29, 2025 |
Sep 29, 2025 |
1 AOP
|
| 3641 |
2373: Increase, Mis-timed EcR-responsive NR cascade |
988: Decrease, Circulating ETH |
Sep 29, 2025 |
Sep 29, 2025 |
1 AOP
|
| 3642 |
2374: Increase, EcR antagonism |
2375: Decrease, Mis-timed EcR-responsive NR cascade |
Sep 29, 2025 |
Sep 29, 2025 |
2 AOPs
|